Protosera Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
16
- Latest Deal Type
-
M&A
Protosera General Information
Description
Developer of diagnostic and therapeutic drugs intended to discover tests that catch changes in the mind and body due to illness and treat it with biological therapy. The company's solution uses disease-specific protein fragment technology to predict the disease, enabling doctors to diagnose the trouble and cure it quickly without much damage.
Contact Information
Website
www.protosera.co.jp(Operating Subsidiary)
Corporate Office
- 601 NK Building, Kento Innovation Park
- 3-17 Senrioka-Shinmachi
- Settsu, 566-0002
- Japan
Corporate Office
- 601 NK Building, Kento Innovation Park
- 3-17 Senrioka-Shinmachi
- Settsu, 566-0002
- Japan
Protosera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 01-Jan-2021 | Completed | Generating Revenue | |||
| 2. Merger/Acquisition | 28-Jun-2013 | Completed | Generating Revenue | |||
| 1. Later Stage VC | Completed | Generating Revenue |
Protosera Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Protosera Patents
Protosera Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024117521-A | Method of detecting pancreatic cancer | Pending | 17-Feb-2023 | ||
| JP-2024075279-A | Method for preparing sample for mass analysis | Active | 22-Nov-2022 | ||
| JP-7331233-B1 | Method for preparing sample for mass spectrometry | Active | 22-Nov-2022 | ||
| JP-2022068788-A | Evaluation of oxidation stress in mild cognitive impairment | Pending | 22-Oct-2020 | ||
| JP-2021018124-A | Peptide marker related to breast cancer | Active | 19-Jul-2019 |
Protosera Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Protosera Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bio Frontier Partners | Venture Capital | Minority | ||
| Ushio | Corporation | Majority |
Protosera FAQs
-
When was Protosera founded?
Protosera was founded in 2004.
-
Where is Protosera headquartered?
Protosera is headquartered in Settsu, Japan.
-
What is the size of Protosera?
Protosera has 16 total employees.
-
What industry is Protosera in?
Protosera’s primary industry is Discovery Tools (Healthcare).
-
Is Protosera a private or public company?
Protosera is a Private company.
-
What is Protosera’s current revenue?
The current revenue for Protosera is .
-
Who are Protosera’s investors?
Bio Frontier Partners and Ushio have invested in Protosera.
-
When was Protosera acquired?
Protosera was acquired on 01-Jan-2021.
-
Who acquired Protosera?
Protosera was acquired by TOWA Pharmaceutical (Osaka).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
